의료기기 시장 : 유형별, 용도별, 지역별 규모, 점유율 및 성장률, 산업 분석, 인사이트 및 예측(2026-2034년)

Growth Factors of medical devices Market

The global medical devices market represents one of the most critical pillars of modern healthcare, driven by rising disease burden, technological innovation, and expanding access to diagnostic and therapeutic solutions. According to the report timeline, the medical devices market size was valued at USD 572.31 billion in 2025. With increasing adoption of advanced diagnostic tools, surgical instruments, and wearable technologies, the market is projected to reach USD 604.99 billion in 2026. Over the long-term forecast period, continued innovation and growing healthcare demand are expected to push the market to USD 1,032.66 billion by 2034, reflecting strong and sustained global expansion.

Medical devices include a wide range of products such as diagnostic imaging systems, in-vitro diagnostics, cardiovascular devices, orthopedic implants, diabetes care devices, surgical instruments, and wearable health monitors. The increasing prevalence of chronic and acute diseases such as diabetes, cardiovascular disorders, cancer, and neurological conditions has significantly increased patient reliance on diagnostic and interventional medical devices. Rising awareness of early diagnosis and treatment options has further fueled the volume of diagnostic tests and surgical procedures worldwide.

Market Dynamics

A key driver of growth in the medical devices industry is the rising prevalence of chronic diseases and aging population. Globally, the number of patients requiring long-term disease management is increasing, leading to higher demand for monitoring devices, imaging systems, and therapeutic equipment. The expanding geriatric population is particularly contributing to demand for orthopedic, ophthalmic, cardiovascular, and home healthcare devices.

Another important growth factor is increasing investment in research and development. Major manufacturers are focusing on developing technologically advanced, minimally invasive, and patient-centric solutions. Breakthrough device designations and faster regulatory pathways in developed markets are accelerating innovation. Companies such as Medtronic and Johnson & Johnson Services, Inc. continue to invest heavily in next-generation medical technologies to address unmet clinical needs.

However, the market faces restraints due to high costs of advanced medical devices and inadequate reimbursement policies in developing countries. Capital-intensive equipment such as MRI scanners, CT scanners, and robotic surgery systems remain inaccessible to many healthcare facilities in emerging economies. Additionally, limited reimbursement coverage for advanced procedures restricts adoption in price-sensitive markets.

Market Opportunities and Challenges

The medical devices market presents strong opportunities through increased R&D investments and expansion into emerging markets. Rising healthcare expenditure, improving infrastructure, and growing government focus on healthcare modernization in Asia Pacific, Latin America, and the Middle East & Africa are creating new growth avenues. The shift toward home healthcare and portable medical devices further supports market expansion.

At the same time, stringent and evolving regulatory frameworks pose challenges. Manufacturers must comply with diverse regulatory standards across regions, increasing approval timelines and compliance costs. Trade protectionism and geopolitical tensions also impact supply chains and market access, particularly for cross-border medical device trade.

Market Trends

A prominent trend shaping the medical devices industry is the growing preference for wearable and remote monitoring devices. Increasing health consciousness and digital health adoption have driven demand for smartwatches, fitness trackers, and remote diagnostic tools. These devices enable continuous health monitoring and early detection, supporting preventive healthcare models.

Other notable trends include the rise of personalized medicine, increasing use of artificial intelligence in diagnostics and imaging, and growing demand for minimally invasive surgical procedures that reduce hospital stays and improve patient outcomes.

Segmentation Insights

By type, in-vitro diagnostics (IVD) held the largest market share in 2025, supported by the high volume of clinical diagnostic tests and rising infectious and chronic disease prevalence. Diabetes care devices and minimally invasive surgery devices are also experiencing strong growth due to increasing disease burden and procedural volumes.

By end-user, hospitals and ambulatory surgery centers (ASCs) dominated the market in 2026, driven by high patient inflow, availability of advanced equipment, and expansion of multispecialty healthcare facilities.

Regional Outlook

North America dominated the medical devices market with a 38.1% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of innovative technologies. Europe remains a significant market due to strong regulatory frameworks and growing home healthcare adoption. Asia Pacific is emerging as a high-growth region, driven by large patient populations, rising healthcare investments, and expanding manufacturing capabilities in countries such as China, India, and Japan.

Competitive Landscape

The global medical devices market is fragmented, with key players such as GE Healthcare, Stryker, Abbott, and Siemens Healthineers AG focusing on product innovation, acquisitions, and geographic expansion. Strategic collaborations, regulatory approvals, and portfolio diversification remain central to maintaining competitive advantage.

Aligned strictly with the report years 2025, 2026, and 2034, the medical devices industry is set to expand steadily, supported by rising healthcare demand, continuous technological advancement, and increasing global focus on early diagnosis, effective treatment, and patient-centric care.

Conclusion

The global medical devices industry is positioned for consistent and long-term growth, supported by rising healthcare demand, technological advancement, and expanding access to diagnostic and therapeutic solutions. Valued at USD 572.31 billion in 2025, the market's progression to USD 604.99 billion in 2026 reflects strong adoption of advanced diagnostic tools, minimally invasive surgical systems, and wearable health technologies. The projected expansion to USD 1,032.66 billion by 2034 underscores the industry's critical role in addressing the growing burden of chronic diseases and an aging global population.

While high device costs, reimbursement limitations in developing regions, and complex regulatory frameworks remain key challenges, sustained investments in research and development, rapid innovation, and expansion into emerging markets continue to create new growth opportunities. Regional leadership by North America, steady advancement in Europe, and high-growth momentum in Asia Pacific indicate a well-balanced global expansion. Overall, aligned strictly with the report years 2025, 2026, and 2034, the medical devices market is expected to remain resilient and innovation-driven, playing a central role in improving patient outcomes and strengthening healthcare systems worldwide.

Segmentation By Type

• Orthopedic Devices
• Cardiovascular Devices
• Diagnostic Imaging Devices
• In-vitro Diagnostic (IVD)
• Minimally Invasive Surgery Devices
• Wound Management
• Diabetes Care Devices
• Ophthalmic Devices
• Dental Devices
• Nephrology Devices
• General Surgery
• Others

By End-User

• Hospitals & ASCs
• Clinics
• Others

By Region

• North America (By Type, End-User, and Country)
  • U.S. (By Type and End-User)
  • Canada (By Type and End-User)
• Europe (By Type, End-User, and Country/Sub-region)
  • U.K. (By Type and End-User)
  • Germany (By Type and End-User)
  • France (By Type and End-User)
  • Italy (By Type and End-User)
  • Spain (By Type and End-User)
  • Rest of Europe (By Type and End-User)
• Asia Pacific (By Type, End-User, and Country/Sub-region)
  • China (By Type and End-User)
  • Japan (By Type and End-User)
  • India (By Type and End-User)
  • Australia (By Type and End-User)
  • Rest of Asia Pacific (By Type and End-User)
• Latin America (By Type, End-User, and Country/Sub-region)
  • Brazil (By Type and End-User)
  • Mexico (By Type and End-User)
  • Rest of Latin America (By Type and End-User)
• Middle East & Africa (By Type, End-User, and Country/ Sub-region)
  • GCC (By Type and End-User)
  • South Africa (By Type and End-User)
• Rest of Middle East & Africa (By Type and End-User)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Overview of Healthcare Expenditure by Key Countries, 2024/2025
• 4.2. New Product Launches, by Key Players for COVID-19
• 4.3. Recent Industry Developments - Mergers & Acquisitions
• 4.4. Technological Advancements
• 4.5. Key Industry Trends
• 4.6. Impact of COVID-19 on the Medical Devices Market

5. Global Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Orthopedic Devices
  • 5.1.2. Cardiovascular Devices
  • 5.1.3. Diagnostic Imaging Devices
  • 5.1.4. In-vitro Diagnostics (IVD)
  • 5.1.5. Minimally Invasive Surgery Devices
  • 5.1.6. Wound Management
  • 5.1.7. Diabetes Care Devices
  • 5.1.8. Ophthalmic Devices
  • 5.1.9. Nephrology Devices
  • 5.1.10. Dental Devices
  • 5.1.11. General Surgery
  • 5.1.12. Others
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Hospitals & ASCs
  • 5.2.2. Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Geography
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Orthopedic Devices
  • 6.1.2. Cardiovascular Devices
  • 6.1.3. Diagnostic Imaging Devices
  • 6.1.4. In-vitro Diagnostics (IVD)
  • 6.1.5. Minimally Invasive Surgery Devices
  • 6.1.6. Wound Management
  • 6.1.7. Diabetes Care Devices
  • 6.1.8. Ophthalmic Devices
  • 6.1.9. Nephrology Devices
  • 6.1.10. Dental Devices
  • 6.1.11. General Surgery
  • 6.1.12. Others
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Hospitals & ASCs
  • 6.2.2. Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. U.S. Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 6.4.1. Market Analysis, Insights and Forecast - By Type
    • 6.4.1.1. Orthopedic Devices
    • 6.4.1.2. Cardiovascular Devices
    • 6.4.1.3. Diagnostic Imaging Devices
    • 6.4.1.4. In-vitro Diagnostics (IVD)
    • 6.4.1.5. Minimally Invasive Surgery Devices
    • 6.4.1.6. Wound Management
    • 6.4.1.7. Diabetes Care Devices
    • 6.4.1.8. Ophthalmic Devices
    • 6.4.1.9. Nephrology Devices
    • 6.4.1.10. Dental Devices
    • 6.4.1.11. General Surgery
    • 6.4.1.12. Others
  • 6.4.2. Market Analysis, Insights and Forecast - By End User
    • 6.4.2.1. Hospitals & ASCs
    • 6.4.2.2. Clinics
    • 6.4.2.3. Others
• 6.5. Canada Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 6.5.1. Market Analysis, Insights and Forecast - By Type
    • 6.5.1.1. Orthopedic Devices
    • 6.5.1.2. Cardiovascular Devices
    • 6.5.1.3. Diagnostic Imaging Devices
    • 6.5.1.4. In-vitro Diagnostics (IVD)
    • 6.5.1.5. Minimally Invasive Surgery Devices
    • 6.5.1.6. Wound Management
    • 6.5.1.7. Diabetes Care Devices
    • 6.5.1.8. Ophthalmic Devices
    • 6.5.1.9. Nephrology Devices
    • 6.5.1.10. Dental Devices
    • 6.5.1.11. General Surgery
    • 6.5.1.12. Others
  • 6.5.2. Market Analysis, Insights and Forecast - By End User
    • 6.5.2.1. Hospitals & ASCs
    • 6.5.2.2. Clinics
    • 6.5.2.3. Others

7. Europe Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Orthopedic Devices
  • 7.1.2. Cardiovascular Devices
  • 7.1.3. Diagnostic Imaging Devices
  • 7.1.4. In-vitro Diagnostics (IVD)
  • 7.1.5. Minimally Invasive Surgery Devices
  • 7.1.6. Wound Management
  • 7.1.7. Diabetes Care Devices
  • 7.1.8. Ophthalmic Devices
  • 7.1.9. Nephrology Devices
  • 7.1.10. Dental Devices
  • 7.1.11. General Surgery
  • 7.1.12. Others
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Hospitals & ASCs
  • 7.2.2. Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Rest of Europe
• 7.4. U.K. Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.4.1. Market Analysis, Insights and Forecast - By Type
    • 7.4.1.1. Orthopedic Devices
    • 7.4.1.2. Cardiovascular Devices
    • 7.4.1.3. Diagnostic Imaging Devices
    • 7.4.1.4. In-vitro Diagnostics (IVD)
    • 7.4.1.5. Minimally Invasive Surgery Devices
    • 7.4.1.6. Wound Management
    • 7.4.1.7. Diabetes Care Devices
    • 7.4.1.8. Ophthalmic Devices
    • 7.4.1.9. Nephrology Devices
    • 7.4.1.10. Dental Devices
    • 7.4.1.11. General Surgery
    • 7.4.1.12. Others
  • 7.4.2. Market Analysis, Insights and Forecast - By End User
    • 7.4.2.1. Hospitals & ASCs
    • 7.4.2.2. Clinics
    • 7.4.2.3. Others
• 7.5. Germany Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.5.1. Market Analysis, Insights and Forecast - By Type
    • 7.5.1.1. Orthopedic Devices
    • 7.5.1.2. Cardiovascular Devices
    • 7.5.1.3. Diagnostic Imaging Devices
    • 7.5.1.4. In-vitro Diagnostics (IVD)
    • 7.5.1.5. Minimally Invasive Surgery Devices
    • 7.5.1.6. Wound Management
    • 7.5.1.7. Diabetes Care Devices
    • 7.5.1.8. Ophthalmic Devices
    • 7.5.1.9. Nephrology Devices
    • 7.5.1.10. Dental Devices
    • 7.5.1.11. General Surgery
    • 7.5.1.12. Others
  • 7.5.2. Market Analysis, Insights and Forecast - By End User
    • 7.5.2.1. Hospitals & ASCs
    • 7.5.2.2. Clinics
    • 7.5.2.3. Others
• 7.6. France Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.6.1. Market Analysis, Insights and Forecast - By Type
    • 7.6.1.1. Orthopedic Devices
    • 7.6.1.2. Cardiovascular Devices
    • 7.6.1.3. Diagnostic Imaging Devices
    • 7.6.1.4. In-vitro Diagnostics (IVD)
    • 7.6.1.5. Minimally Invasive Surgery Devices
    • 7.6.1.6. Wound Management
    • 7.6.1.7. Diabetes Care Devices
    • 7.6.1.8. Ophthalmic Devices
    • 7.6.1.9. Nephrology Devices
    • 7.6.1.10. Dental Devices
    • 7.6.1.11. General Surgery
    • 7.6.1.12. Others
  • 7.6.2. Market Analysis, Insights and Forecast - By End User
    • 7.6.2.1. Hospitals & ASCs
    • 7.6.2.2. Clinics
    • 7.6.2.3. Others
• 7.7. Italy Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.7.1. Market Analysis, Insights and Forecast - By Type
    • 7.7.1.1. Orthopedic Devices
    • 7.7.1.2. Cardiovascular Devices
    • 7.7.1.3. Diagnostic Imaging Devices
    • 7.7.1.4. In-vitro Diagnostics (IVD)
    • 7.7.1.5. Minimally Invasive Surgery Devices
    • 7.7.1.6. Wound Management
    • 7.7.1.7. Diabetes Care Devices
    • 7.7.1.8. Ophthalmic Devices
    • 7.7.1.9. Nephrology Devices
    • 7.7.1.10. Dental Devices
    • 7.7.1.11. General Surgery
    • 7.7.1.12. Others
  • 7.7.2. Market Analysis, Insights and Forecast - By End User
    • 7.7.2.1. Hospitals & ASCs
    • 7.7.2.2. Clinics
    • 7.7.2.3. Others
• 7.8. Spain Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.8.1. Market Analysis, Insights and Forecast - By Type
    • 7.8.1.1. Orthopedic Devices
    • 7.8.1.2. Cardiovascular Devices
    • 7.8.1.3. Diagnostic Imaging Devices
    • 7.8.1.4. In-vitro Diagnostics (IVD)
    • 7.8.1.5. Minimally Invasive Surgery Devices
    • 7.8.1.6. Wound Management
    • 7.8.1.7. Diabetes Care Devices
    • 7.8.1.8. Ophthalmic Devices
    • 7.8.1.9. Nephrology Devices
    • 7.8.1.10. Dental Devices
    • 7.8.1.11. General Surgery
    • 7.8.1.12. Others
  • 7.8.2. Market Analysis, Insights and Forecast - By End User
    • 7.8.2.1. Hospitals & ASCs
    • 7.8.2.2. Clinics
    • 7.8.2.3. Others
• 7.9. Rest of Europe Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.9.1. Market Analysis, Insights and Forecast - By Type
    • 7.9.1.1. Orthopedic Devices
    • 7.9.1.2. Cardiovascular Devices
    • 7.9.1.3. Diagnostic Imaging Devices
    • 7.9.1.4. In-vitro Diagnostics (IVD)
    • 7.9.1.5. Minimally Invasive Surgery Devices
    • 7.9.1.6. Wound Management
    • 7.9.1.7. Diabetes Care Devices
    • 7.9.1.8. Ophthalmic Devices
    • 7.9.1.9. Nephrology Devices
    • 7.9.1.10. Dental Devices
    • 7.9.1.11. General Surgery
    • 7.9.1.12. Others
  • 7.9.2. Market Analysis, Insights and Forecast - By End User
    • 7.9.2.1. Hospitals & ASCs
    • 7.9.2.2. Clinics
    • 7.9.2.3. Others

8. Asia Pacific Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Orthopedic Devices
  • 8.1.2. Cardiovascular Devices
  • 8.1.3. Diagnostic Imaging Devices
  • 8.1.4. In-vitro Diagnostics (IVD)
  • 8.1.5. Minimally Invasive Surgery Devices
  • 8.1.6. Wound Management
  • 8.1.7. Diabetes Care Devices
  • 8.1.8. Ophthalmic Devices
  • 8.1.9. Nephrology Devices
  • 8.1.10. Dental Devices
  • 8.1.11. General Surgery
  • 8.1.12. Others
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Hospitals & ASCs
  • 8.2.2. Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific
• 8.4. China Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.4.1. Market Analysis, Insights and Forecast - By Type
    • 8.4.1.1. Orthopedic Devices
    • 8.4.1.2. Cardiovascular Devices
    • 8.4.1.3. Diagnostic Imaging Devices
    • 8.4.1.4. In-vitro Diagnostics (IVD)
    • 8.4.1.5. Minimally Invasive Surgery Devices
    • 8.4.1.6. Wound Management
    • 8.4.1.7. Diabetes Care Devices
    • 8.4.1.8. Ophthalmic Devices
    • 8.4.1.9. Nephrology Devices
    • 8.4.1.10. Dental Devices
    • 8.4.1.11. General Surgery
    • 8.4.1.12. Others
  • 8.4.2. Market Analysis, Insights and Forecast - By End User
    • 8.4.2.1. Hospitals & ASCs
    • 8.4.2.2. Clinics
    • 8.4.2.3. Others
• 8.5. Japan Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.5.1. Market Analysis, Insights and Forecast - By Type
    • 8.5.1.1. Orthopedic Devices
    • 8.5.1.2. Cardiovascular Devices
    • 8.5.1.3. Diagnostic Imaging Devices
    • 8.5.1.4. In-vitro Diagnostics (IVD)
    • 8.5.1.5. Minimally Invasive Surgery Devices
    • 8.5.1.6. Wound Management
    • 8.5.1.7. Diabetes Care Devices
    • 8.5.1.8. Ophthalmic Devices
    • 8.5.1.9. Nephrology Devices
    • 8.5.1.10. Dental Devices
    • 8.5.1.11. General Surgery
    • 8.5.1.12. Others
  • 8.5.2. Market Analysis, Insights and Forecast - By End User
    • 8.5.2.1. Hospitals & ASCs
    • 8.5.2.2. Clinics
    • 8.5.2.3. Others
• 8.6. India Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.6.1. Market Analysis, Insights and Forecast - By Type
    • 8.6.1.1. Orthopedic Devices
    • 8.6.1.2. Cardiovascular Devices
    • 8.6.1.3. Diagnostic Imaging Devices
    • 8.6.1.4. In-vitro Diagnostics (IVD)
    • 8.6.1.5. Minimally Invasive Surgery Devices
    • 8.6.1.6. Wound Management
    • 8.6.1.7. Diabetes Care Devices
    • 8.6.1.8. Ophthalmic Devices
    • 8.6.1.9. Nephrology Devices
    • 8.6.1.10. Dental Devices
    • 8.6.1.11. General Surgery
    • 8.6.1.12. Others
  • 8.6.2. Market Analysis, Insights and Forecast - By End User
    • 8.6.2.1. Hospitals & ASCs
    • 8.6.2.2. Clinics
    • 8.6.2.3. Others
• 8.7. Australia Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.7.1. Market Analysis, Insights and Forecast - By Type
    • 8.7.1.1. Orthopedic Devices
    • 8.7.1.2. Cardiovascular Devices
    • 8.7.1.3. Diagnostic Imaging Devices
    • 8.7.1.4. In-vitro Diagnostics (IVD)
    • 8.7.1.5. Minimally Invasive Surgery Devices
    • 8.7.1.6. Wound Management
    • 8.7.1.7. Diabetes Care Devices
    • 8.7.1.8. Ophthalmic Devices
    • 8.7.1.9. Nephrology Devices
    • 8.7.1.10. Dental Devices
    • 8.7.1.11. General Surgery
    • 8.7.1.12. Others
  • 8.7.2. Market Analysis, Insights and Forecast - By End User
    • 8.7.2.1. Hospitals & ASCs
    • 8.7.2.2. Clinics
    • 8.7.2.3. Others
• 8.8. Rest of Asia Pacific Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.8.1. Market Analysis, Insights and Forecast - By Type
    • 8.8.1.1. Orthopedic Devices
    • 8.8.1.2. Cardiovascular Devices
    • 8.8.1.3. Diagnostic Imaging Devices
    • 8.8.1.4. In-vitro Diagnostics (IVD)
    • 8.8.1.5. Minimally Invasive Surgery Devices
    • 8.8.1.6. Wound Management
    • 8.8.1.7. Diabetes Care Devices
    • 8.8.1.8. Ophthalmic Devices
    • 8.8.1.9. Nephrology Devices
    • 8.8.1.10. Dental Devices
    • 8.8.1.11. General Surgery
    • 8.8.1.12. Others
  • 8.8.2. Market Analysis, Insights and Forecast - By End User
    • 8.8.2.1. Hospitals & ASCs
    • 8.8.2.2. Clinics
    • 8.8.2.3. Others

9. Latin America Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Orthopedic Devices
  • 9.1.2. Cardiovascular Devices
  • 9.1.3. Diagnostic Imaging Devices
  • 9.1.4. In-vitro Diagnostics (IVD)
  • 9.1.5. Minimally Invasive Surgery Devices
  • 9.1.6. Wound Management
  • 9.1.7. Diabetes Care Devices
  • 9.1.8. Ophthalmic Devices
  • 9.1.9. Nephrology Devices
  • 9.1.10. Dental Devices
  • 9.1.11. General Surgery
  • 9.1.12. Others
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Hospitals & ASCs
  • 9.2.2. Clinics
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America
• 9.4. Brazil Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.4.1. Market Analysis, Insights and Forecast - By Type
    • 9.4.1.1. Orthopedic Devices
    • 9.4.1.2. Cardiovascular Devices
    • 9.4.1.3. Diagnostic Imaging Devices
    • 9.4.1.4. In-vitro Diagnostics (IVD)
    • 9.4.1.5. Minimally Invasive Surgery Devices
    • 9.4.1.6. Wound Management
    • 9.4.1.7. Diabetes Care Devices
    • 9.4.1.8. Ophthalmic Devices
    • 9.4.1.9. Nephrology Devices
    • 9.4.1.10. Dental Devices
    • 9.4.1.11. General Surgery
    • 9.4.1.12. Others
  • 9.4.2. Market Analysis, Insights and Forecast - By End User
    • 9.4.2.1. Hospitals & ASCs
    • 9.4.2.2. Clinics
    • 9.4.2.3. Others
• 9.5. Mexico Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.5.1. Market Analysis, Insights and Forecast - By Type
    • 9.5.1.1. Orthopedic Devices
    • 9.5.1.2. Cardiovascular Devices
    • 9.5.1.3. Diagnostic Imaging Devices
    • 9.5.1.4. In-vitro Diagnostics (IVD)
    • 9.5.1.5. Minimally Invasive Surgery Devices
    • 9.5.1.6. Wound Management
    • 9.5.1.7. Diabetes Care Devices
    • 9.5.1.8. Ophthalmic Devices
    • 9.5.1.9. Nephrology Devices
    • 9.5.1.10. Dental Devices
    • 9.5.1.11. General Surgery
    • 9.5.1.12. Others
  • 9.5.2. Market Analysis, Insights and Forecast - By End User
    • 9.5.2.1. Hospitals & ASCs
    • 9.5.2.2. Clinics
    • 9.5.2.3. Others
• 9.6. Rest of Latin America Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.6.1. Market Analysis, Insights and Forecast - By Type
    • 9.6.1.1. Orthopedic Devices
    • 9.6.1.2. Cardiovascular Devices
    • 9.6.1.3. Diagnostic Imaging Devices
    • 9.6.1.4. In-vitro Diagnostics (IVD)
    • 9.6.1.5. Minimally Invasive Surgery Devices
    • 9.6.1.6. Wound Management
    • 9.6.1.7. Diabetes Care Devices
    • 9.6.1.8. Ophthalmic Devices
    • 9.6.1.9. Nephrology Devices
    • 9.6.1.10. Dental Devices
    • 9.6.1.11. General Surgery
    • 9.6.1.12. Others
  • 9.6.2. Market Analysis, Insights and Forecast - By End User
    • 9.6.2.1. Hospitals & ASCs
    • 9.6.2.2. Clinics
    • 9.6.2.3. Others

10. Middle East & Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Orthopedic Devices
  • 10.1.2. Cardiovascular Devices
  • 10.1.3. Diagnostic Imaging Devices
  • 10.1.4. In-vitro Diagnostics (IVD)
  • 10.1.5. Minimally Invasive Surgery Devices
  • 10.1.6. Wound Management
  • 10.1.7. Diabetes Care Devices
  • 10.1.8. Ophthalmic Devices
  • 10.1.9. Nephrology Devices
  • 10.1.10. Dental Devices
  • 10.1.11. General Surgery
  • 10.1.12. Others
• 10.2. Market Analysis, Insights and Forecast - By End User
  • 10.2.1. Hospitals & ASCs
  • 10.2.2. Clinics
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa
• 10.4. GCC Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.4.1. Market Analysis, Insights and Forecast - By Type
    • 10.4.1.1. Orthopedic Devices
    • 10.4.1.2. Cardiovascular Devices
    • 10.4.1.3. Diagnostic Imaging Devices
    • 10.4.1.4. In-vitro Diagnostics (IVD)
    • 10.4.1.5. Minimally Invasive Surgery Devices
    • 10.4.1.6. Wound Management
    • 10.4.1.7. Diabetes Care Devices
    • 10.4.1.8. Ophthalmic Devices
    • 10.4.1.9. Nephrology Devices
    • 10.4.1.10. Dental Devices
    • 10.4.1.11. General Surgery
    • 10.4.1.12. Others
  • 10.4.2. Market Analysis, Insights and Forecast - By End User
    • 10.4.2.1. Hospitals & ASCs
    • 10.4.2.2. Clinics
    • 10.4.2.3. Others
• 10.5. South Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.5.1. Market Analysis, Insights and Forecast - By Type
    • 10.5.1.1. Orthopedic Devices
    • 10.5.1.2. Cardiovascular Devices
    • 10.5.1.3. Diagnostic Imaging Devices
    • 10.5.1.4. In-vitro Diagnostics (IVD)
    • 10.5.1.5. Minimally Invasive Surgery Devices
    • 10.5.1.6. Wound Management
    • 10.5.1.7. Diabetes Care Devices
    • 10.5.1.8. Ophthalmic Devices
    • 10.5.1.9. Nephrology Devices
    • 10.5.1.10. Dental Devices
    • 10.5.1.11. General Surgery
    • 10.5.1.12. Others
  • 10.5.2. Market Analysis, Insights and Forecast - By End User
    • 10.5.2.1. Hospitals & ASCs
    • 10.5.2.2. Clinics
    • 10.5.2.3. Others
• 10.6. Rest of Middle East & Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.6.1. Market Analysis, Insights and Forecast - By Type
    • 10.6.1.1. Orthopedic Devices
    • 10.6.1.2. Cardiovascular Devices
    • 10.6.1.3. Diagnostic Imaging Devices
    • 10.6.1.4. In-vitro Diagnostics (IVD)
    • 10.6.1.5. Minimally Invasive Surgery Devices
    • 10.6.1.6. Wound Management
    • 10.6.1.7. Diabetes Care Devices
    • 10.6.1.8. Ophthalmic Devices
    • 10.6.1.9. Nephrology Devices
    • 10.6.1.10. Dental Devices
    • 10.6.1.11. General Surgery
    • 10.6.1.12. Others
  • 10.6.2. Market Analysis, Insights and Forecast - By End User
    • 10.6.2.1. Hospitals & ASCs
    • 10.6.2.2. Clinics
    • 10.6.2.3. Others

11. Analysis of the High-Medium-Low Impact of COVID-19

• 11.1. Medical Device Market Segments
  • 11.1.1. High Impact
  • 11.1.2. Medium Impact
  • 11.1.3. Low Impact
• 11.2. Key Medical Device Companies
  • 11.2.1. High Impact
  • 11.2.2. Medium Impact
  • 11.2.3. Low Impact

12. Competitive Analysis

• 12.1. Global Market Share Analysis (2025)
• 12.2. Profiles of Players Operating in the Market
  • 12.2.1. Medtronic
    • 12.2.1.1. Overview
    • 12.2.1.2. Products
    • 12.2.1.3. SWOT Analysis
    • 12.2.1.4. Recent Developments
    • 12.2.1.5. Strategies
    • 12.2.1.6. Financials (Based on Availability)
  • 12.2.2. Abbott
    • 12.2.2.1. Overview
    • 12.2.2.2. Products
    • 12.2.2.3. SWOT Analysis
    • 12.2.2.4. Recent Developments
    • 12.2.2.5. Strategies
    • 12.2.2.6. Financials (Based on Availability)
  • 12.2.3. Siemens Healthineers AG
    • 12.2.3.1. Overview
    • 12.2.3.2. Products
    • 12.2.3.3. SWOT Analysis
    • 12.2.3.4. Recent Developments
    • 12.2.3.5. Strategies
    • 12.2.3.6. Financials (Based on Availability)
  • 12.2.4. Johnson & Johnson Services, Inc.
    • 12.2.4.1. Overview
    • 12.2.4.2. Products
    • 12.2.4.3. SWOT Analysis
    • 12.2.4.4. Recent Developments
    • 12.2.4.5. Strategies
    • 12.2.4.6. Financials (Based on Availability)
  • 12.2.5. Koninklijke Philips N.V.
    • 12.2.5.1. Overview
    • 12.2.5.2. Products
    • 12.2.5.3. SWOT Analysis
    • 12.2.5.4. Recent Developments
    • 12.2.5.5. Strategies
    • 12.2.5.6. Financials (Based on Availability)
  • 12.2.6. Stryker
    • 12.2.6.1. Overview
    • 12.2.6.2. Products
    • 12.2.6.3. SWOT Analysis
    • 12.2.6.4. Recent Developments
    • 12.2.6.5. Strategies
    • 12.2.6.6. Financials (Based on Availability)
  • 12.2.7. F. Hoffmann-La Roche AG
    • 12.2.7.1. Overview
    • 12.2.7.2. Products
    • 12.2.7.3. SWOT Analysis
    • 12.2.7.4. Recent Developments
    • 12.2.7.5. Strategies
    • 12.2.7.6. Financials (Based on Availability)
  • 12.2.8. BD
    • 12.2.8.1. Overview
    • 12.2.8.2. Products
    • 12.2.8.3. SWOT Analysis
    • 12.2.8.4. Recent Developments
    • 12.2.8.5. Strategies
    • 12.2.8.6. Financials (Based on Availability)
  • 12.2.9. GE Healthcare
    • 12.2.9.1. Overview
    • 12.2.9.2. Products
    • 12.2.9.3. SWOT Analysis
    • 12.2.9.4. Recent Developments
    • 12.2.9.5. Strategies
    • 12.2.9.6. Financials (Based on Availability)
  • 12.2.10. Boston Scientific Corporation
    • 12.2.10.1. Overview
    • 12.2.10.2. Products
    • 12.2.10.3. SWOT Analysis
    • 12.2.10.4. Recent Developments
    • 12.2.10.5. Strategies
    • 12.2.10.6. Financials (Based on Availability)
  • 12.2.11. Fresenius Medical Care AG & Co. KGaA
    • 12.2.11.1. Overview
    • 12.2.11.2. Products
    • 12.2.11.3. SWOT Analysis
    • 12.2.11.4. Recent Developments
    • 12.2.11.5. Strategies
    • 12.2.11.6. Financials (Based on Availability)